1. Introduction {#sec1-brainsci-09-00117}
===============

Cognition in childhood determines cognitive ability in later life in healthy persons \[[@B1-brainsci-09-00117]\] and influences cognition in those with dementia \[[@B2-brainsci-09-00117]\]. Therefore, it is important to consider peak adult intelligence (IQ), also referred to as "premorbid IQ", when assessing cognitive ability in later life to allow for the examination of cognitive decline \[[@B3-brainsci-09-00117]\]. Premorbid IQ refers to an individual's level of intellectual functioning prior to declines associated with ageing, neurological events, or both \[[@B4-brainsci-09-00117]\]. Declining cognitive ability in the years preceding the stroke can be measured with tests, such as the Informant Questionnaire on Cognitive Decline (IQCODE) \[[@B5-brainsci-09-00117]\], but post-stroke cognitive impairment is common and premorbid IQ is an important predictor \[[@B6-brainsci-09-00117],[@B7-brainsci-09-00117]\]. Changes in cognitive ability are clinically important, therefore, the availability of stable and reliable estimates of premorbid IQ are vital so that we can accurately examine risk factors for post-stroke cognitive decline.

As actual IQ scores from early adulthood are rarely available, methods of estimation have been developed. Widely accepted measures, such as the National Adult Reading Test (NART) \[[@B8-brainsci-09-00117]\], assess vocabulary and pronunciation skills, which are considered as "crystallized intelligence" and remain unaffected by neurological events or impairment \[[@B8-brainsci-09-00117]\]. Using the NART, premorbid IQ (NART IQ) can be estimated based on the number of correct responses (NART score). The NART has been shown to relate well to current IQ scores in healthy individuals \[[@B9-brainsci-09-00117]\] and to childhood IQ for individuals with and without dementia \[[@B2-brainsci-09-00117]\]. It has been used in different neurological disorders \[[@B10-brainsci-09-00117]\] and has been shown to have good consistency over periods up to 7.5 years \[[@B11-brainsci-09-00117],[@B12-brainsci-09-00117]\]. However, some evidence suggests that it can over- or under-estimate \[[@B9-brainsci-09-00117]\] and is less reliable in some patient populations \[[@B13-brainsci-09-00117]\].

To our knowledge, the stability of the NART after stroke has not been examined. Furthermore, there is a scarcity of studies examining longitudinal changes in premorbid IQ (which should be stable) and current cognitive ability (which declines with age).

We aimed to investigate: Whether the NART is a valid test of premorbid IQ after stroke by examining the relationship between time after stroke with changes in NART IQ, and current cognitive ability (i.e., how do estimated premorbid IQ and current cognitive ability scores change between follow-up time-points). We will also examine whether the relationships with time remain after controlling for baseline demographic and stroke characteristics. Due to the obvious relationship between age and time, we examine the relationship between age, estimated premorbid IQ and cognitive ability at one to three months post-stroke.Whether certain baseline demographic or stroke characteristics predict changes in NART IQ and current cognition scores between two time-points post-stroke.

2. Materials and Methods {#sec2-brainsci-09-00117}
========================

2.1. Recruitment {#sec2dot1-brainsci-09-00117}
----------------

Patients (over 18 years) with recent minor ischemic stroke were recruited into the Mild Stroke Study II (MSSII) between May 2010 and May 2012. This prospective study consecutively recruited in- and outpatients with minor ischemic stroke admitted to the Lothian Stroke Services, Scotland. Patients who were unable to consent (e.g., lacked capacity due to cognitive impairment), medically unlikely to participate in long-term follow-up and had aphasia were excluded (details previously described) \[[@B7-brainsci-09-00117],[@B14-brainsci-09-00117]\].

Minor ischemic stroke was defined as sudden onset of focal neurological symptoms lasting \>24 hours, a National Institutes of Health Stroke Scale (NIHSS) score of \<8, that was not expected to result in long-term dependency (modified Rankin score (mRS) ≤ 3). Based on the clinical stroke syndrome and MRI appearance of the acute lesion, the index stroke was classified as "cortical" or "lacunar" \[[@B15-brainsci-09-00117]\]. MRI including diffusion-weighted imaging (DWI) was performed using a 1.5 Tesla GE Sigma HDxt scanner \[[@B14-brainsci-09-00117]\]. White matter hyperintensities (WMH) were rated using the Fazekas score \[[@B16-brainsci-09-00117]\], blind to clinical and cognitive information \[[@B14-brainsci-09-00117]\].

2.2. Follow-Up Assessments {#sec2dot2-brainsci-09-00117}
--------------------------

Following recruitment and baseline clinical assessment, patients were invited for cognitive assessment at one to three months, and one and three years' post-index stroke. Only those who were seen for in-person assessment were offered cognitive assessment. Follow-up at one to three months and 1 year were performed in the hospital. At three years', participants unable to attend the hospital were offered a home visit or telephone interview.

We assessed premorbid IQ using the NART and current cognitive ability using the Addenbrooke's Cognitive Examination--Revised (ACE-R) \[[@B17-brainsci-09-00117]\] at all three time-points. The NART consists of 50 phonetically irregular words, which participants read aloud. The ACE-R is a multi-domain cognitive screening tool used to identify those with cognitive impairment. Assessments were completed by trained researchers, experienced in the administration of these neuropsychological screening tools. In addition, we collected information relating to socio-demographic, vascular risk factors, lifestyle variables, and recurrent vascular events including stroke \[[@B6-brainsci-09-00117]\].

This study was approved by the Lothian Ethics of Medical Research Committee (REC 09/81, 101/54) and the NHS Lothian Research and Development Office (2009/W/NEU/14). All participants gave written informed consent at each time-point.

2.3. Statistical Analysis {#sec2dot3-brainsci-09-00117}
-------------------------

Several methods of calculating premorbid IQ using NART errors scores are available. We calculated "NART IQ" based on the number of correctly pronounced words on the NART using the equation: 127.7 − 0.826 × (50 − NART score) \[[@B8-brainsci-09-00117]\]. Mild and severe cognitive impairment were defined as ACE-R scores 83--88 and ≤82, respectively \[[@B17-brainsci-09-00117]\].

We used Wilcoxon rank-sum test (*W*), *t*-test and chi-square tests to compare those with NART IQ and ACE-R versus those without (questionnaire only and no follow-up), tested at each time-point based on demographics, lifestyle, and stroke characteristics.

### 2.3.1. Aim 1 {#sec2dot3dot1-brainsci-09-00117}

We used a series of paired t-tests to examine whether NART IQ and ACE-R scores significantly differed between one to three months and one year, and one and three years (mean differences (MD)). We used linear mixed models to examine whether the associations between time and NART IQ or ACE-R scores were affected by baseline characteristics (i.e., when adjusting for baseline factors, does the association between time and NART IQ or ACE-R scores differ from that seen in paired *t*-tests). We included baseline demographic (age, sex, and years of education), stroke characteristics (stroke subtype (cortical/lacunar), stroke severity (NIHSS score, 0--8), Fazekas score (0--6)), and vascular and lifestyle risk factors (hypertension (yes/no), smoking status (current and less than 1 year ex-smoker/more than 1 year ex-smoker and never smoked)) factors. However, our models showed poor model fit: Model residuals were non-normal ([Figure S1](#app1-brainsci-09-00117){ref-type="app"}) and could not be improved through standard data transformations. Therefore, results should be interpreted with caution. Due to the obvious relationship between age and time, we explored the relationships between NART IQ and ACE-R with age using linear regression.

### 2.3.2. Aim 2 {#sec2dot3dot2-brainsci-09-00117}

We examined predictors of change in NART IQ and ACE-R scores between each time-point by including an interaction with time in our linear mixed effect models. To increase power, we examined the interaction between time and each baseline demographic and stroke variable in separate models resulting in a series of strongly related and overlapping models. It is important to note that we hoped to identify effect which may be of interest in future research, therefore, we did not adjust for multiple comparisons \[[@B18-brainsci-09-00117]\].

3. Results {#sec3-brainsci-09-00117}
==========

3.1. Patient Characteristics {#sec3dot1-brainsci-09-00117}
----------------------------

At baseline, 264 patients with minor ischemic stroke were included (mean age 66.40, SD 11.84, 154 (58.33%) male, [Figure 1](#brainsci-09-00117-f001){ref-type="fig"}). Cognitive testing was offered to 208 (78.79%) at one to three months post-index stroke and 158 (59.85%) patients completed the assessment. Patients were followed-up for cognitive assessment at one (151, 57.20%) and three years' post-index stroke (153, 57.95%). Those with cognitive follow-up had less severe stroke (one to three months), were younger, had more years of education (both one year) and differed on smoking status (three years) compared to those without cognitive follow-up. Additionally, those with cognitive follow-up at one year also had higher NART IQ and ACE-R scores at one to three months and those with cognitive follow-up at three years had higher one year ACE-R scores. There were no other significant differences in demographic or stroke characteristics at each time-point ([Table 1](#brainsci-09-00117-t001){ref-type="table"}). Across all time-points, NART IQ scores ranged from 92.18 to 127.70/127.70 and ACE-R scores ranged from 54 to 100/100 ([Table 2](#brainsci-09-00117-t002){ref-type="table"}).

3.2. Aim 1: Changes in Estimated Premorbid IQ and Current Cognitive Ability over Time {#sec3dot2-brainsci-09-00117}
-------------------------------------------------------------------------------------

### 3.2.1. NART IQ {#sec3dot2dot1-brainsci-09-00117}

Estimated premorbid IQ (NART IQ) changed significantly between all three time-points ([Table 2](#brainsci-09-00117-t002){ref-type="table"}, [Figure 2](#brainsci-09-00117-f002){ref-type="fig"}a). Between one to three months and one year (*n* = 124), NART IQ significantly increased by a MD of 1.332 points (95% CI 0.536 to 2.129, *p* = 0.001). During this period, 77/124 (62%) improved, 35/124 (28%) declined, and 12/124 (10%) did not change.

Between one and three years (*n* = 101), NART IQ decreased significantly by −4.269 points (95% CI −5.124 to −3.414, *p* \< 0.001). During this period, 12/101 (12%) improved, 82/101 (81%) declined, and 7/101 (7%) did not change.

Overall, between one to three months and three years (*n* = 100), NART IQ decreased significantly (−3.155, 95% CI −3.991 to −2.319, *p* \< 0.001). The majority (78/100, 78%) of participants showed a decline.

The associations between time and NART IQ scores after controlling for baseline and stroke characteristics remained significantly positive (*b* = 1.453, 95% CI = 0.657 to 2.270, *p* \< 0.001) at one to three months and one year, and significantly negative at one and three years (*b* = −4.474, 95% CI= −5.345 to −3.631, *p* \< 0.001, [Table 3](#brainsci-09-00117-t003){ref-type="table"})

### 3.2.2. ACE-R {#sec3dot2dot2-brainsci-09-00117}

Current cognitive ability (ACE-R) remained generally more stable across all three time-points ([Table 2](#brainsci-09-00117-t002){ref-type="table"} and [Figure 2](#brainsci-09-00117-f002){ref-type="fig"}b). Between one to three months and one year (*n* = 135), ACE-R scores did not change significantly (0.289, 95% CI −0.488 to 1.065, *p* = 0.463). During this period, 61/135 (45%) patients improved, 54/135 (40%) declined, and 20/135 (15%) did not change.

Between one and three years (*n* = 106), ACE-R scores declined significantly (−1.047, 95% CI −2.082 to −0.012, *p* = 0.047). During this period, 42/106 (40%) patients improved, 57/106 (54%) declined, and 7/106 (7%) did not change.

Overall, between one to three months and three years (*n* = 101), 48/101 (48%) improved, 42/101 (16%) declined, and 11/101 (10%) did not change, however the overall change was not significant (0.178, 95% CI −1.354 to 0.997, *p* = 0.764).

The associations between time and ACE-R scores remained unchanged after controlling for baseline and stroke characteristics: Positive, but non-significant, at one to three months and one year (*b* = 0.403, 95% CI = −0.375 to 1.195, *p* = 0.312) and significantly negative at one and three years (*b* = −1.028, 95% CI = −2.039 to −0.003, *p* = 0.047, [Table 3](#brainsci-09-00117-t003){ref-type="table"}).

### 3.2.3. Sensitivity Analysis {#sec3dot2dot3-brainsci-09-00117}

Including only patients with cognitive data at all three time-points did not change the patterns of NART IQ (*n* = 90) and ACE-R (*n* = 96) scores ([Tables S1 and S2](#app1-brainsci-09-00117){ref-type="app"} and [Figure 2](#brainsci-09-00117-f002){ref-type="fig"}c,d).

### 3.2.4. The Relationship between Age and Estimated Premorbid IQ (NART IQ) and Current Cognitive Ability (ACE-R) {#sec3dot2dot4-brainsci-09-00117}

The relationship between age with NART IQ and ACE-R scores were in different directions. Age was positively associated with NART IQ at one to three months post-stroke (i.e., there was a trend for those with older age at entry into study having higher NART IQ), however this association was non-significant (*b* = 0.069, 95% CI = −0.048 to 0.181, *p* = 0.24, [Figure 3](#brainsci-09-00117-f003){ref-type="fig"}). For ACE-R, the relationship between age and ACE-R was negative (i.e., older age at entry into study was associated with lower current cognitive ability). This association was significant (*b* = −0.210, 95% CI = −0.314 to −0.107, *p* \< 0.001, [Figure 3](#brainsci-09-00117-f003){ref-type="fig"}).

3.3. Aim 2: Predictors of Changes between Time-Points {#sec3dot3-brainsci-09-00117}
-----------------------------------------------------

### 3.3.1. NART IQ {#sec3dot3dot1-brainsci-09-00117}

More years of education was associated with increases in NART IQ between one to three months and one year (*b* = 1.165, 95% CI = 0.721 to 1.608), *p* \< 0.001), and smaller decreases between one and three years' (*b* = 1.046, 95% CI = 0.598 to 1.495, *p* \< 0.001). There were no other significant interactions suggesting that no other baseline demographics or stroke characteristics were associated with changes in NART IQ ([Table 4](#brainsci-09-00117-t004){ref-type="table"} and [Table S3](#app1-brainsci-09-00117){ref-type="app"}).

### 3.3.2. ACE-R {#sec3dot3dot2-brainsci-09-00117}

Older age was associated with declines in ACE-R scores between one to three months (*b* = −0.202, 95% CI = −0.311 to −0.093, *p* \< 0.001), and one and three years' (*b* = −0.137, 95% CI = −0.255 to −0.019, *p* = 0.024). Increases in ACE-R were associated with higher NART IQ (one to three months and one year: *b* = 0.345, 95% CI = 0.229 to 0.461, *p* \< 0.001, one and three years: *b* = 0.416, 95% CI = 0.286 to 0.546, *p* \< 0.001) and more education (one to three months and one year: *b* = 0.603, 95% CI = 0.229 to 0.977, *p* = 0.002, and one and three years: *b* = 0.501, 95% CI = 0.113 to 0.888, *p* = 0.012). In addition, increases in ACE-R between one to three months and one year were associated with having hypertension (*b* = 2.943, 95% CI = 0.605 to 5.280, *p* = 0.014). There were no other significant interactions ([Table 5](#brainsci-09-00117-t005){ref-type="table"} and [Table S4](#app1-brainsci-09-00117){ref-type="app"}).

4. Discussion {#sec4-brainsci-09-00117}
=============

We assessed patients with minor ischaemic stroke over a follow-up period of three years assessing the stability of both estimated premorbid IQ and current cognitive ability using established measures. To our knowledge, this is the first study to assess the stability of the NART post-stroke and one of a few studies to assess current cognition to three years post-stroke. Our findings suggest that post-stroke cognitive change is complex. We show fluctuations in NART IQ scores with a significant increase between one to three months and one year, followed by a significant decrease between one and three years' post-index stroke. For ACE-R scores, we found that scores remained mostly stable between first assessment at between one to three months and second assessment at one year, followed by a small, but significant, decrease by the third assessment at three years. Adjusting for baseline demographic and stroke characteristics did not change these trajectories. Increases in both NART IQ and ACE-R scores post-stroke were associated with more education. Additionally, higher NART IQ and older age were associated with changes in ACE-R scores (increases and decreases respectively). Despite including relevant outcome predictors (e.g., age, stroke severity, WMH volume etc.), the poor model fit may reflect the lack of relevant variables that contribute to cognitive ability scores. This highlights the need for future research closely examining variables associated with changes in both estimated premorbid and current cognitive ability to better understand post-stroke cognitive trajectories.

The stability of the NART in other conditions has shown mixed findings. Although, the NART has been shown to be a stable estimate of premorbid IQ in healthy individuals \[[@B19-brainsci-09-00117]\] and patients with schizophrenia (mean age 35 years) \[[@B11-brainsci-09-00117]\] over one and 7.5 years respectively, small but significant decreases have been shown in healthy older individuals \[[@B20-brainsci-09-00117]\] and those with dementia \[[@B21-brainsci-09-00117]\]. Furthermore, improvements in NART performance has also been shown in traumatic brain injury (TBI) \[[@B22-brainsci-09-00117],[@B23-brainsci-09-00117]\] demonstrating the complex interaction of disease variables, age, education and time post-injury affecting NART performance.

Symptoms such as post-stroke fatigue and speech disturbances are common \[[@B24-brainsci-09-00117],[@B25-brainsci-09-00117]\] and may affect NART performance shortly after stroke. Symptom improvement may explain the initial increase in NART IQ, however these variables would also affect ACE-R performance, which is not seen here. Furthermore, factors associated with declining NART performance, such as increasing rates of dementia, were not frequently observed in our study and recurrent stroke between the one and three year follow-up was uncommon (*n* = 12, 8%).

We show only a small, albeit significant, decrease in current cognitive ability (ACE-R) between one and three years'. Although cognitive ability declines with increasing age \[[@B26-brainsci-09-00117],[@B27-brainsci-09-00117]\] and post-stroke dementia is common \[[@B28-brainsci-09-00117]\], studies show mixed post-stroke cognitive trajectories \[[@B29-brainsci-09-00117]\]. Improvements in global cognition are seen in some studies with short follow-up periods (up to three months) \[[@B30-brainsci-09-00117]\], while those with longer follow-up periods (up to six years) report declines \[[@B31-brainsci-09-00117]\].

We show a significant negative relationship between age and current cognitive ability, however the association between NART IQ and age is less clear. Research in individuals from the general population has shown better crystallized intelligence in older adults \[[@B32-brainsci-09-00117]\], although some studies have demonstrated a negative relationship between age and NART \[[@B13-brainsci-09-00117]\]. We show a weak, non-significant, positive association such that individuals entered into the study having had a stroke at older ages had marginally higher NART IQ, although this association was non-significant. If true in other studies of post-stroke cognition, then age is a source of confounding and variation in premorbid IQ may account for poor prediction of post-stroke cognitive impairment.

We did not find that adjusting for demographic and stroke characteristics, including age, altered the association between time and changes in ACE-R and NART IQ. This suggests that other unidentified factors are contributing to this pattern of results. Future research should focus on the identification of factors influencing longitudinal changes in premorbid IQ in stroke patients to enable the accurate prediction and identification of those at risk of poor post-stroke cognitive outcomes.

Strengths and Limitations
-------------------------

Although the MSSII achieved good follow-up at all three time-points, we found some evidence of possible participation bias as those with follow-up had better previous ACE-R and NART IQ scores. This may have contributed to the overall stability of current cognitive ability, however the trends in both NART IQ and ACE-R scores remained the same when only those with cognitive data at all time-points were examined and when accounting for baseline demographic and stroke characteristics. Furthermore, we used linear mixed effect models to examine factors associated with change which is unaffected by missing data points and accounts for different starting points (i.e., someone who decreases from NART IQ of 120 to 117 is not necessarily the same as someone who decreases from 90 to 97).

Cognitive assessment were administered by one rater at one to three months and one year and different raters at three years' which may have resulted in some variability. This is particularly true with the NART, which relies on the subjective assessment of correct pronunciation, however the inter-rater reliability of the NART has previously shown to be good \[[@B22-brainsci-09-00117],[@B33-brainsci-09-00117],[@B34-brainsci-09-00117]\] and all researchers administering the assessments had undergone the same training.

5. Conclusions {#sec5-brainsci-09-00117}
==============

Overall, we show an interesting dichotomy with declines in estimates of premorbid IQ, while current cognitive ability scores remain more stable. These findings suggest caution in the use of the NART to estimate premorbid IQ after stroke, although its use is more beneficial than having no measure. Future research in post-stroke cognition should try to account for premorbid IQ since it is a major predictor of post-stroke cognition and health in general and should closely examine what factors influence changes in premorbid IQ following stroke so that more reliable estimates can be obtained.

The following are available online at <https://www.mdpi.com/2076-3425/9/5/117/s1>, Figure S1: Residual plots for linear mixed models examining the associations between time, demographic and vascular risk factors with NART IQ and ACE-R scores by time-point, Table S1: NART IQ and ACE-R scores at each time-point for patients with data available at all time-points, Table S2: Linear mixed effects model showing the associations between time and NART IQ and ACE-R adjusted for baseline characteristics for patients with data available at all time-points, Table S3: Full linear mixed effects models showing factors associated with changes in NART IQ at each time-point, Table S4: Full linear mixed effects models showing factors associated with changes in current ACE-R scores at each time-point.
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brainsci-09-00117-t001_Table 1

###### 

Baseline characteristics of patients with cognitive data by time-point.

                                     One to Three Months (*n* = 158)   1 Year (*n* = 151)   3 Years (*n* = 153)                                      
  ---------------------------------- --------------------------------- -------------------- --------------------- ------------------ --------------- ---------------------------
  **Demographics**                                                                                                                                   
  Age at index stroke                65.09 ± 11.82                     W = 9544.5           65.01 ± 11.02         W = 9845 \*        65.50 ± 11.18   W = 9476.5
  Sex: Male                          93 (58.86%)                       *χ*^2^ = 0.007       93 (61.59%)           *χ*^2^ = 1.242     83 (54.25%)     *χ*^2^ = 2.115
  Years of Education ^a^             11.71 ± 2.94                      W = 876.5            11.88 ± 3.02          W = 1098.5 \*      12.04 ± 3.11    W = 2633
  Smoker:                                                              *χ*^2^ = 2.954                             *χ*^2^ = 7.551                     *χ*^2^ = 12.256 \*
  Yes                                48 (30.38%)                                            42 (27.81%)                              43 (28.29%)     
  No                                 56 (35.44%)                                            58 (38.41%)                              61 (40.13%)     
  Ex-smoker (for more than 1 year)   47 (29.75%)                                            44 (29.14%)                              44 (28.95)      
  Ex-smoker (for less than 1 year)   7 (4.43%)                                              7 (4.64%)                                4 (2.63)        
  **Stroke Characteristics**                                                                                                                         
  Stroke subtype:                                                      *χ*^2^ = 0.287                             *χ*^2^ = 0.998                     *χ*^2^ = 0.224
  Cortical                           90 (56.96%)                                            88 (58.28%)                              87 (56.86%)     
  Lacunar                            68 (43.04%)                                            63 (41.72%)                              66 (43.14%)     
  Stroke severity (NIHSS)            1.00 (1.00)                       W = 9853.5 \*        1.00 (1.00)           W = 9319.5         1.00 (2.00)     W = 7709
  **Cognitive Variables**                                                                                                                            
  ACE-R                              88.09 ± 8.17                      \-                   88.93 ± 7.98          W = 815 \*\*^,b^   88.32 ± 8.92    W = 2512/W = 1864 \*^,c^
  NART IQ                            115.40 ± 8.60                     \-                   117.56 ± 8.61         W = 1031 \*^,b^    112.28 ± 8.40   W = 2549.5/W = 1998.5 ^c^

^a^ Collected at the 1-year follow-up; ^b^ baseline scores; ^c^ baseline/1-year follow-up scores; \* *p* \< 0.05; \*\* *p* \< 0.001; W = Wilcoxon rank-sum test; *χ*^2^ = chi-square test; ACE-R = Addenbrooke's Cognitive Examination-Revised; NART IQ = Premorbid IQ estimated using The National Adult Reading Test.

brainsci-09-00117-t002_Table 2

###### 

NART IQ and ACE-R scores at and between each time-point for all patients with data available at each time-point.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                  Scores                              Change in Scores                                                                        
  ------------------------------- ----------------- ----------------- ------------------ ---------------------- --------------------- ----------------------- ----------------------
                                  **NART IQ**                                                                                                                 

  *n*                             154               140               153                *n*                    124                   101                     100

  Mean ± SD\                      115.40 ± 8.60\    117.56 ± 8.61\    112.28 ± 8.40\     Mean change (95% CI)   1.322\                −4.269\                 −3.155\
  (range)                         (92.18--127.70)   (93.08--127.70)   (92.18--127.70)                           (0.54 to 2.13) \*\*   (−5.12 to −3.41) \*\*   (−3.99 to 2.32) \*\*

                                                                                         Decreased *n* (%)      35 (28.23%)           82 (81.19%)             78 (78.00%)

                                                                                         Increased *n* (%)      77 (62.10%)           12 (11.88%)             15 (15.00%)

                                                                                         No change *n* (%)      12 (9.68%)            7 (6.93%)               7 (7.00%)

                                  **ACE-R**                                                                                                                   

  *n*                             157               151               151                *n*                    135                   106                     101

  Mean ± SD (range)               88.09 ± 8.17\     88.93 ± 7.98\     88.32 ± 8.92\      Mean change (95% CI)   0.289\                −1.047\                 −0.178\
                                  (59.00--100.0)    (59.00--100.0)    (54.00--100.0)                            (−0.49 to 1.07)       (−2.08 to −0.01) \*     (−1.35 to 1.00)

  No impairment *n* (%) ^a^       91 (57.96%)       91 (60.26%)       85 (56.29%)        Decreased *n* (%)      54 (40.00%)           57 (53.77%)             42 (41.58%)

  Mild impairment *n* (%) ^b^     28 (17.83%        28 (18.54%)       35 (23.18%)        Increased *n* (%)      61 (45.19%)           42 (39.62%)             48 (47.52%)

  Severe impairment *n* (%) ^c^   38 (24.20%)       32 (21.19%)       31 (20.53%)        No change *n* (%)      20 (14.81%)           7 (6.60%)               11 (10.89%)
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\* *p* \< 0.05; \*\* *p* \< 0.001; ^a^ ACE-R scores ≥ 89; ^b^ ACE-R scores 83--88; ^c^ ACE-R scores ≤ 82.

brainsci-09-00117-t003_Table 3

###### 

Linear mixed effects model showing the associations between time and NART IQ and ACE-R adjusted for baseline characteristics.

                             1--3 Months and 1 Year   1--3 Years                                                      
  -------------------------- ------------------------ ------------------- ----------- ---------- -------------------- -----------
                             **NART IQ**                                                                              
  Time (years)               *1.453*                  *(0.657, 2.270)*    *\<0.001*   *−4.474*   *(−5.345, −3.631)*   *\<0.001*
  Age                        0.100                    (−0.026, 0.225)     0.118       0.099      (−0.039, 0.237)      0.170
  Sex (male)                 1.232                    (−1.222, 3.587)     0.316       1.497      (−1.005, 3.999)      0.253
  Baseline Fazekas           0.166                    (−0.639, 0.973)     0.692       −0.002     (−0.870, 0.865)      0.996
  Stroke subtype (lacunar)   1.047                    (−1.401, 3.495)     0.413       0.893      (−1.721, 3.508)      0.514
  NIHSS                      −0.214                   (−1.306, 0.877)     0.707       0.032      (−1.120, 1.182)      0.958
  Hypertension (yes)         2.815                    (0.222, 5.409)      0.075       2.304      (−0.466, 5.075)      0.112
  Smoker (yes)               −0.536                   (−3.158, 2.086)     0.696       −1.574     (−4.397, 1.251)      0.287
  Years of education         1.287                    (0.877, 1.697)      \<0.001     1.193      (0.775, 1.612)       \<0.001
                             **ACE-R**                                                                                
  Time (years)               *0.403*                  *(−0.375, 1.195)*   *0.312*     *−1.028*   *(−2.039, −0.003)*   *0.047*
  Age                        −0.194                   (−0.308, −0.080)    0.001       −0.162     (−0.292, −0.032)     0.017
  Sex (male)                 0.362                    (−1.758, 2.479)     0.743       0.392      (−1.947, 2.732)      0.749
  Baseline Fazekas           −0.316                   (−1.039, 0.410)     0.403       −0.692     (−1.499, 0.114)      0.101
  Stroke subtype (lacunar)   0.728                    (−1.474, 2.927)     0.526       1.376      (−1.070, 3.825)      0.282
  NIHSS                      −0.421                   (−1.398, 0.556)     0.410       −0.316     (−1.382, 0.749)      0.571
  Hypertension (yes)         3.709                    (1.380, 6.037)      0.002       3.465      (0.864, 6.066)       0.011
  Smoker (yes)               −0.355                   (−2.716, 2.009)     0.772       −0.182     (−2.819, 2.461)      0.895
  Years of education         0.952                    (0.581, 1.322)      \<0.001     1.009      (0.615, 1.404)       \<0.001

NART IQ = Premorbid IQ estimated using the National Adult Reading Test; ACE-R = Addenbrooke's Cognitive Examination-Revised. Results in italics highlight the estimates of interest showing that the relationships between time and changes in NART-IQ and ACE-R remain after adjusting for baseline characteristics.
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###### 

Linear mixed effects models showing factors associated with changes in NART IQ at each time-point.

  Variable                   Variation in NART IQ with Variable at:   Change in NART IQ between:   Change in NART IQ with Variable at:                                                                    
  -------------------------- ---------------------------------------- ---------------------------- ------------------------------------- -------- ------------------ --------- -------- ----------------- ---------
  Age                        0.095                                    (−0.038, 0.229)              0.160                                 1.339    (−3.545, 6.223)    0.588     0.097    (−0.039, 0.233)   0.160
  Sex                        1.546                                    (−0.998, 4.090)              0.231                                 1.878    (0.582, 3.173)     0.005     0.847    (−1.760, 3.453)   0.521
  Baseline Fazekas           0.402                                    (−0.458, 1.262)              0.357                                 2.954    (1.306, 4.602)     \<0.001   −0.123   (−1.004, 0.758)   0.782
  Stroke subtype (lacunar)   0.704                                    (−1.926, 3.334)              0.597                                 1.122    (0.035, 2.210)     0.043     1.454    (−1.238, 4.145)   0.287
  NIHSS                      −0.340                                   (−1.513, 0.833)              0.567                                 1.163    (0.066, 2.260)     0.038     −0.062   (−1.253, 1.130)   0.918
  Hypertension (yes)         2.970                                    (0.162, 5.778)               0.038                                 1.695    (0.121, 3.269)     0.035     2.642    (−0.222, 5.506)   0.070
  Smoker (yes)               −0.256                                   (−3.073, 2.562)              0.858                                 1.672    (0.692, 2.651)     0.001     −0.957   (−3.836, 1.923)   0.512
  Years of education         1.400                                    (0.958, 1.842)               \<0.001                               4.277    (1.060, 7.494)     0.010     1.165    (0.721, 1.608)    \<0.001
                             **1 Year**                               **1 and 3 Years**            **3 Years**                                                                                            
  Age                        0.098                                    (−0.061, 0.257)              0.223                                 −2.107   (−4.706, 0.492)    0.111     0.0963   (−0.050, 0.243)   0.194
  Sex                        1.214                                    (−1.866, 4.293)              0.436                                 −2.327   (−2.997, −1.657)   \<0.001   1.3677   (−1.345, 4.081)   0.319
  Baseline Fazekas           −0.242                                   (−1.281, 0.797)              0.644                                 −2.633   (−3.551, −1.716)   \<0.001   −0.103   (−1.035, 0.828)   0.826
  Stroke subtype (lacunar)   2.980                                    (−0.160, 6.119)              0.063                                 −1.723   (−2.283, −1.164)   \<0.001   1.842    (−0.979, 4.663)   0.198
  NIHSS                      0.213                                    (−1.166, 1.592)              0.760                                 −2.129   (−2.727, −1.531)   \<0.001   0.116    (−1.122, 1.354)   0.852
  Hypertension (yes)         2.012                                    (−1.383, 5.406)              0.242                                 −2.36    (−3.215, −1.505)   \<0.001   2.176    (−0.815, 5.168)   0.152
  Smoker (yes)               −1.051                                   (−4.446, 2.344)              0.540                                 −2.152   (−2.658, −1.646)   \<0.001   −1.369   (−4.393, 1.656)   0.371
  Years of education         0.873                                    (0.375, 1.372)               0.001                                 −4.332   (−6.003, −2.661)   \<0.001   1.046    (0.598, 1.495)    \<0.001

All estimates are adjusted for the other variables in the model. Each row represents an individual, but strongly related, overlapping model. Full tables for each model can be found in [Table S3](#app1-brainsci-09-00117){ref-type="app"}.
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###### 

Linear mixed effects models showing factors associated with changes in current ACE-R scores at each time point.

  Variable                   Variation in ACE-R with variable at:   Change in ACE-R between:   Change in ACE-R with variable at:                                                                    
  -------------------------- -------------------------------------- -------------------------- ----------------------------------- --------- ------------------ ------- -------- ------------------ ---------
  Age                        −0.239                                 (−0.345, −0.133)           \<0.001                             −2.191    (−7.337, 2.954)    0.401   −0.202   (−0.311, −0.093)   \<0.001
  Sex (male)                 −0.370                                 (−2.417, 1.677)            0.721                               −0.001    (−1.389, 1.387)    0.999   −0.030   (−2.150, 2.090)    0.977
  Baseline Fazekas           −0.221                                 (−0.915, 0.473)            0.529                               0.207     (1.597, 2.011)     0.820   −0.222   (−0.937, 0.494)    0.541
  Stroke subtype (lacunar)   −0.327                                 (−2.433, 1778)             0.759                               −0.020    (−1.177, 1.137)    0.973   0.191    (−1.995, 2.377)    0.863
  NIHSS                      −0.609                                 (−1.541, 0.323)            0.198                               −0.536    (−1.683, 0.612)    0.357   0.115    (−0.840, 1.070)    0.812
  Hypertension (yes)         2.761                                  (0.499, 5.033)             0.018                               0.073     (−1.601, 1.746)    0.932   2.943    (0.605, 5.280)     0.014
  Smoker (yes)               0.388                                  (−1.859, 2.635)            0.733                               0.595     (−0.452, 1.642)    0.263   −0.835   (−3.165, 1.494)    0.479
  NART IQ                    0.290                                  (0.171, 0.408)             0.000                               −6.217    (−18.303, 5.869)   0.310   0.345    (0.229, 0.461)     \<0.001
  Years of education         0.407                                  (0.026, 0.788)             0.037                               −2.157    (−5.616, 1.302)    0.219   0.603    (0.229, 0.977)     0.002
                             **1 Year**                             **1 and 3 Years**          **3 Years**                                                                                          
  Age                        −0.054                                 (−0.196, 0.087)            0.447                               5.771     (2.560, 8.981)     0.001   −0.137   (−0.255, −0.019)   0.024
  Sex (male)                 1.016                                  (−1,928, 3.960)            0.495                               0.803     (−0.114, 1.720)    0.085   0.370    (−1.882, 2.622)    0.745
  Baseline Fazekas           −0.123                                 (−1.088, 0.842)            0.801                               1.250     (0.018, 2.482)     0.047   −0.407   (−1.167, 0.353)    0.291
  Stroke subtype (lacunar)   −1.008                                 (−3.990, 1.974)            0.504                               \<0.001   (−0.783, 0.783)    0.999   0.022    (−2.291, 2.335)    0.985
  NIHSS                      0.227                                  (−1.063, 1.517)            0.727                               0.683     (−0.138, 1.504)    0.102   −0.005   (−1.011, 1.000)    0.992
  Hypertension (yes)         2.378                                  (−0.875, 5.632)            0.150                               0.444     (−0.709, 1.598)    0.446   2.367    (−0.108, 4.843)    0.061
  Smoker (yes)               −1.491                                 (−4.670, 1.689)            0.354                               0.089     (−0.619, 0.796)    0.804   −0.226   (−2.697, 2.245)    0.856
  NART IQ                    0.380                                  (0.211, 0.549)             \<0.001                             −3.704    (−11.427, 4.020)   0.343   0.416    (0.286, 0.546)     \<0.001
  Years of education         0.548                                  (0.064, 1.032)             0.027                               1.019     (−1.312, 3.350)    0.387   0.501    (0.113, 0.888)     0.012

All estimates are adjusted for the other variables in the model. Each row represents an individual, but strongly related, overlapping model. Full tables for each model can be found in [Table S4](#app1-brainsci-09-00117){ref-type="app"}.
